LU80063A1 - Procede de preparation d'un vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c - Google Patents
Procede de preparation d'un vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe cInfo
- Publication number
- LU80063A1 LU80063A1 LU80063A LU80063A LU80063A1 LU 80063 A1 LU80063 A1 LU 80063A1 LU 80063 A LU80063 A LU 80063A LU 80063 A LU80063 A LU 80063A LU 80063 A1 LU80063 A1 LU 80063A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- vaccine
- preparation
- high molecular
- molecular mass
- mass against
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/820,665 US4123520A (en) | 1977-08-01 | 1977-08-01 | Method for preparing high molecular weight meningococcal Group C vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU80063A1 true LU80063A1 (fr) | 1979-05-15 |
Family
ID=25231420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU80063A LU80063A1 (fr) | 1977-08-01 | 1978-07-31 | Procede de preparation d'un vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4123520A (fi) |
| JP (1) | JPS5446893A (fi) |
| AR (1) | AR222974A1 (fi) |
| BE (1) | BE869406A (fi) |
| CA (1) | CA1112566A (fi) |
| DE (1) | DE2833545A1 (fi) |
| DK (1) | DK308578A (fi) |
| EG (1) | EG13435A (fi) |
| FI (1) | FI59024C (fi) |
| FR (1) | FR2399252A1 (fi) |
| GB (1) | GB2001530B (fi) |
| IE (1) | IE47149B1 (fi) |
| IT (1) | IT1107462B (fi) |
| LU (1) | LU80063A1 (fi) |
| NL (1) | NL7807419A (fi) |
| ZA (1) | ZA784324B (fi) |
| ZM (1) | ZM6778A1 (fi) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2460139A1 (fr) * | 1979-06-29 | 1981-01-23 | Pasteur Institut | Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction |
| BE889979A (fr) * | 1981-08-14 | 1982-02-15 | Smith Kline Rit | Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation |
| EP0109688A3 (en) * | 1982-11-23 | 1986-12-03 | The Wellcome Foundation Limited | Improved complexes, processes for obtaining them and formulations containing such complexes |
| US5370871A (en) * | 1983-01-24 | 1994-12-06 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
| DE3483957D1 (de) * | 1983-11-21 | 1991-02-21 | Wellcome Found | Komplexe, verfahren zu ihrer herstellung und dieselben enthaltende formulierungen. |
| US4681761A (en) * | 1985-10-24 | 1987-07-21 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine |
| FR2619122B1 (fr) * | 1987-08-03 | 1990-03-09 | Pasteur Institut | Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede |
| US4877613A (en) * | 1987-08-05 | 1989-10-31 | Biotech Connections, Inc. | Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli |
| US5225194A (en) * | 1989-11-13 | 1993-07-06 | Ldc Research Corporation | Aqueous diafiltration process for preparing acellular vaccines, against selected bacterial diseases |
| US5506129A (en) * | 1991-05-24 | 1996-04-09 | Evans Medical Limited | Virus production |
| US20040213806A1 (en) * | 1998-08-28 | 2004-10-28 | Smithkline Beecham Biologicals, S.A. | Salmonella typhi vaccine compositions |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| PE20070163A1 (es) | 2005-06-27 | 2007-03-01 | Glaxosmithkline Biolog Sa | Composicion inmunogenica de conjugados de sacaridos de n. meningitidis |
| US7491517B2 (en) * | 2006-07-19 | 2009-02-17 | Jeeri R Reddy | Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3636192A (en) * | 1970-01-13 | 1972-01-18 | Us Army | Meningococcal polysaccharide vaccines |
-
1977
- 1977-08-01 US US05/820,665 patent/US4123520A/en not_active Expired - Lifetime
-
1978
- 1978-07-10 DK DK308578A patent/DK308578A/da not_active Application Discontinuation
- 1978-07-10 FI FI782204A patent/FI59024C/fi not_active IP Right Cessation
- 1978-07-10 NL NL787807419A patent/NL7807419A/xx not_active Application Discontinuation
- 1978-07-24 ZM ZM67/78A patent/ZM6778A1/xx unknown
- 1978-07-24 IT IT50445/78A patent/IT1107462B/it active
- 1978-07-28 GB GB787831459A patent/GB2001530B/en not_active Expired
- 1978-07-28 AR AR273125A patent/AR222974A1/es active
- 1978-07-28 FR FR7822448A patent/FR2399252A1/fr active Granted
- 1978-07-30 EG EG471/78A patent/EG13435A/xx active
- 1978-07-31 DE DE19782833545 patent/DE2833545A1/de not_active Ceased
- 1978-07-31 ZA ZA784324A patent/ZA784324B/xx unknown
- 1978-07-31 IE IE1541/78A patent/IE47149B1/en unknown
- 1978-07-31 LU LU80063A patent/LU80063A1/xx unknown
- 1978-07-31 JP JP9265978A patent/JPS5446893A/ja active Pending
- 1978-07-31 BE BE189615A patent/BE869406A/xx not_active IP Right Cessation
- 1978-07-31 CA CA308,467A patent/CA1112566A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK308578A (da) | 1979-02-02 |
| EG13435A (en) | 1981-06-30 |
| IE47149B1 (en) | 1983-12-28 |
| FI782204A (fi) | 1979-02-02 |
| FR2399252B1 (fi) | 1981-07-31 |
| BE869406A (fr) | 1979-01-31 |
| ZM6778A1 (en) | 1980-06-20 |
| GB2001530A (en) | 1979-02-07 |
| NL7807419A (nl) | 1979-02-05 |
| CA1112566A (en) | 1981-11-17 |
| US4123520A (en) | 1978-10-31 |
| FI59024B (fi) | 1981-02-27 |
| IT7850445A0 (it) | 1978-07-24 |
| FR2399252A1 (fr) | 1979-03-02 |
| AR222974A1 (es) | 1981-07-15 |
| GB2001530B (en) | 1982-03-03 |
| JPS5446893A (en) | 1979-04-13 |
| FI59024C (fi) | 1981-06-10 |
| DE2833545A1 (de) | 1979-02-15 |
| ZA784324B (en) | 1980-03-26 |
| IT1107462B (it) | 1985-11-25 |
| IE781541L (en) | 1979-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU80063A1 (fr) | Procede de preparation d'un vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c | |
| PL204214A1 (pl) | Sposob wytwarzania preparatu bialka surowicy do podawania dozylnego | |
| DE2862384D1 (en) | O-substituted (+)-cyanidan-3-ol derivatives, method for their preparation, as well as pharmaceutical compositions containing these compounds and their preparation | |
| BE858992A (fr) | Procede de preparation de vaccins | |
| BE863676A (fr) | Vaccin syncytial du virus respiratoires | |
| DE2860893D1 (en) | Lipopeptides, process for their preparation and pharmaceutical compositions containing them | |
| FR2310994A1 (fr) | Procede de preparation et d'obtention de composes aromatiques mononitres | |
| FR2476658B1 (fr) | Procede perfectionne de preparation d'un polyester de masse moleculaire elevee | |
| NL7808717A (nl) | Levend vaccin tegen pasteurella multocida. | |
| RO71908A (ro) | Procedeu pentru prepararea unor esteri ai acidului 7 beta-acilamino-3-clor-3-cefem-4-carboxilic | |
| NL990018I1 (nl) | Vaccin tegen Pasteurella. | |
| PT88524A (pt) | Process of preparation of a vaccine for the protection of birdsagainst contagions by mycoplasma and the preparation of a pure culture of the same | |
| BE839306A (fr) | Vaccin d'immunisation active contre l'hepatite virale et procede de preparation | |
| BE863089A (fr) | Inhibiteur d'alpha-amylase, son procede de preparation a partir d'un streptomycete et son application en therapeutique | |
| ATE10498T1 (de) | Durch purinbasen substituierte alkylamino-desoxy1.4;3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung. | |
| PT68267A (fr) | Procede de preparation de derives d'oxadiazole-1,2,4 et leur application en therapeutique | |
| BE864122A (fr) | Composition de pentapeptide, son procede d'obtention et composition therapeutique en comporatant | |
| BE839913A (fr) | Vaccin polysaccharide de meningocoque | |
| BE882684A (fr) | Procede de preparation d'un vaccin antirabique et vaccin obtenu suivant ce procede | |
| LU80366A1 (de) | Neue 4-phenyl-thieno-(2,3-c)piperidine,verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| FR2338708A1 (fr) | Vaccin contre la panleucopenie des felides et son procede de preparation | |
| NO155976C (no) | Anordning for fremstilling av mekanisk masse. | |
| IT1101270B (it) | Processo per la preparazione di un copolimero di esteri vinilici | |
| PT71500A (de) | Neue 4-phenyl-4,5,6,7-tetrahydro-pyrrolo/2,3-c/ pyridine verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen | |
| DK61378A (da) | 2,4-dichlorphenyl-imidazolyl-ethanoner (oler),fremgangsmaade til deres fremstilling samt deres anvedelse som laegemidler |